Skip to content.
About GPO   |   Newsroom/Media   |   Congressional Relations   |   Inspector General   |   Careers   |   Contact   |   askGPO   |   Help  
 

  FDsys > More Information
(Search string is required)
 

17-2593 - Henry v. Angelini Pharms, Inc., et al.,


Download Files

Metadata

Document in Context
17-2593 - Henry v. Angelini Pharms, Inc., et al.,
January 19, 2018
PDF | More
ORDER signed by District Judge Troy L. Nunley on 01/18/18 ORDERING that, pursuant to 11 Stipulation, Endo Health Solutions, Inc. and Endo Pharmaceuticals, Inc. shall answer or otherwise respond to the Complaint by 02/13/18. (Benson, A.)
January 23, 2018
PDF | More
STIPULATION and ORDER signed by District Judge Troy L. Nunley on 1/22/2018 GRANTING an Extension of Time for Defendant Pharma to file its response to the Complaint until 3/12/2018. (Hunt, G)
February 1, 2018
PDF | More
ORDER signed by District Judge Troy L. Nunley on 1/31/18, ORDERING that Teva Pharmaceuticals USA, Inc., may have an extension of 28 days, until 2/13/2018, to respond to Plaintiff's Complaint. (Kastilahn, A)
February 13, 2018
PDF | More
STIPULATION and ORDER signed by District Judge Troy L. Nunley on 2/12/2018 GRANTING an Extension of Time for defendant to respond to the complaint to 3/12/2018. (Hunt, G)
February 14, 2018
PDF | More
ORDER signed by District Judge Troy L. Nunley on 2/13/18, ORDERING that Defendants Endo Health Solutions, Inc. and Endo Pharmaceuticals, Inc., are GRANTED a second extension of 27 days to answer or otherwise respond to the Complaint no later than 3/12/2018. (Kastilahn, A)
March 13, 2018
PDF | More
STIPULATION and ORDER signed by District Judge Troy L. Nunley on 3/12/18, ORDERING that Plaintiff shall file his amended complaint on or before 3/15/2018. Defendants shall answer or otherwise respond to Plaintiff's forthcoming amended complaint no later than 14 days after its filing. (Kastilahn, A)